Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Dr. Sunil Hingorani Reports from ASCO 2013

Dr. Sunil Hingorani Reports from ASCO 2013

Dr. Sunil Hingorani, a leader in pancreatic cancer research, explains the unique challenges in treating the disease. He shares the results of a Phase I trial that used PEGPH20 in combination with chemotherapy for patients with pancreas cancer. Dr. Hingorani described the trial as a new way to understand why the tumor is resistant to therapy and was encouraged by the initial results.

Related Videos

Dr. Venu Pillarisetty

Dr. Venu Pillarisetty is a surgical oncologist who cares for patients with pancreas cancer and other gastrointestinal malignancies. In this video Dr. Pillarisetty describes the advances that are happening in the treatment of pancreatic cancer. Currently, pancreatic cancer is the disease that has the least successful treatment and the most potential for improvement through research. Pancreatic cancer cells behave very differently than other cancer cells and have a high probability of spreading to the liver, lung and inside the abdomen. For the first time in years, pancreatic cancer treatment is improving with new advances in chemotherapy, immunotherapy and surgical techniques. At SCCA we are pushing new advancements on each of these fronts.

Dr. Gabriela Chiorean Reports from ASCO 2013

Dr. Gabriela Chiorean, a GI medical oncologist, talks with Patient Power about two new therapies for pancreatic cancer patients. The first, a new combination therapy, abraxane plus gemcitabine, is now considered the gold standard for treating patients with metastatic pancreatic cancer. The second is a promising vaccine for pancreatic cancer, called HyperAcute Pancreas, that is aimed at early stage pancreatic cancer patients.

New Treatments for Pancreatic Cancer

Pancreatic cancer is one of the deadliest forms of cancer. Dr. David Byrd talks about exciting new therapies that dissolve the fibrous shell that blocks chemotherapy and anticipates upcoming breakthroughs in the fight against pancreatic cancer. He shares the advantage of personalized medicine, such as tumor profiling, in treating cancer, and talks about the advantages of going to Seattle Cancer Care Alliance.

Dr. Sunil Hingorani

Dr. Sunil Hingorani runs a translational research program dedicated to uncovering mechanisms of pancreas cancer formation and developing new early detection and treatment strategies. In this video, Dr. Hingorani discusses his motivation for researching pancreas cancer as well as some of the challenges pancreas cancer presents. Pancreas cancer has a tendency to spread early in the course of progression. The result is complications that tend to happen more often than in other types of cancer. Optimal treatment for pancreas cancer involves multiple types of therapies and specialties. SCCA brings the patient and all the specialists into one room at the same time to develop a comprehensive care plan. The SCCA is currently developing new kinds of therapies for cancers that are resistant to existing therapies. At the SCCA, we don?t just treat a disease, we treat people.